PharMerica CORP Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- PharMerica CORP treasury stock, value, acquired, cost method for the quarter ending 2016-03-31 was $3.00M, a 31.82% decline year-over-year.
- PharMerica CORP treasury stock, value, acquired, cost method for the quarter ending 2015-12-31 was $0.00.
- PharMerica CORP treasury stock, value, acquired, cost method for the quarter ending 2015-09-30 was $400.00K, a 100.00% increase year-over-year.
- PharMerica CORP treasury stock, value, acquired, cost method for the quarter ending 2015-06-30 was -$500.00K, a 225.00% decline year-over-year.
- PharMerica CORP treasury stock, value, acquired, cost method for fiscal 2015 was $4.30M, a 15.69% decline from fiscal 2014.
- PharMerica CORP treasury stock, value, acquired, cost method for fiscal 2014 was $5.10M, a 68.52% decline from fiscal 2013.
- PharMerica CORP treasury stock, value, acquired, cost method for fiscal 2013 was $16.20M, a 1250.00% increase from fiscal 2012.
- PharMerica CORP treasury stock, value, acquired, cost method for fiscal 2012 was $1.20M, a 500.00% increase from fiscal 2011.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2016-03-31 | $3.00M 10-Q · filed 2016-05-06 | $2.90M derived: sum of 4 quarters · filed 2016-05-06 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $4.30M 10-K · filed 2016-02-26 |
| 2015-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $4.30M derived: sum of 4 quarters · filed 2016-02-26 |
| 2015-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $4.10M derived: sum of 4 quarters · filed 2016-02-26 |
| 2015-03-31 | $4.40M 10-Q · filed 2015-05-07 | $5.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $5.10M 10-K · filed 2016-02-26 |
| 2014-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $15.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $19.20M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $4.50M 10-Q · filed 2014-05-01 | $18.90M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $16.20M 10-K · filed 2016-02-26 |
| 2013-09-30 | $4.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $6.30M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $2.90M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $1.80M 10-Q · filed 2013-05-01 | $2.80M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.20M 10-K · filed 2015-03-02 |
| 2012-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $1.30M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $300.00K derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $200.00K 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $200.00K 10-K · filed 2014-02-28 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | |
| 2010-12-31 | $10.60M 10-K · filed 2013-02-07 |